Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study-Reference-Cited by-同舟云学术

Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study

Published:2018-07-18 Issue:11 Volume:32 Page:1940-1949
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Gordon K.B.¹,Armstrong A.W.²,Han C.³,Foley P.⁴,Song M.³,Wasfi Y.³,You Y.³,Shen Y.‐K.³,Reich K.⁵

Affiliation:

1. Medical College of Wisconsin Milwaukee WI USA

2. University of Southern California Los Angeles CA USA

3. Janssen Research & Development, LLC Spring House PA USA

4. The University of Melbourne St. Vincent's Hospital Melbourne Skin & Cancer Foundation Inc. Carlton VIC Australia

5. Dermatologikum Berlin Berlin Germany

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15012

Reference46 articles.

1. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting

2. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review

3. Increased Antidepressant Drug Exposure in Psoriasis Patients: A Longitudinal Population-based Cohort Study

4. Role of Depression in Quality of Life for Patients with Psoriasis

5. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic review;Journal of Affective Disorders;2024-11

2. Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis;Dermatology and Therapy;2024-08-23

3. Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS);RMD Open;2024-08

4. Psoriasis Comorbidities and Their Treatment Impact;Dermatologic Clinics;2024-07

5. Immune-Targeted Therapies for Depression;The Journal of Clinical Psychiatry;2024-06-24